Financial Ratios WuXi AppTec Co., Ltd.
Equities
603259
CNE1000031K4
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.10 CNY | +0.25% |
|
0.00% | +0.51% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.12 | 5.36 | 9.54 | 9.95 | 9.81 | |||||
Return on Total Capital | 6.44 | 6.79 | 11.93 | 12.07 | 11.73 | |||||
Return On Equity % | 11.91 | 14.37 | 20.78 | 18.94 | 19.93 | |||||
Return on Common Equity | 11.86 | 14.36 | 20.72 | 18.89 | 19.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.88 | 36.14 | 37.19 | 41.09 | 43.49 | |||||
SG&A Margin | 14.68 | 12.67 | 9.04 | 8.87 | 8.13 | |||||
EBITDA Margin % | 23.48 | 23.51 | 26.9 | 32.24 | 38.36 | |||||
EBITA Margin % | 19.02 | 19.32 | 23.47 | 27.52 | 32.1 | |||||
EBIT Margin % | 18.72 | 18.98 | 23.24 | 27.31 | 31.88 | |||||
Income From Continuing Operations Margin % | 18.06 | 22.43 | 22.62 | 24.05 | 30.11 | |||||
Net Income Margin % | 17.9 | 22.26 | 22.4 | 23.81 | 24.92 | |||||
Net Avail. For Common Margin % | 17.86 | 22.26 | 22.4 | 23.81 | 29.8 | |||||
Normalized Net Income Margin | 11.87 | 15.17 | 14.99 | 17.72 | 21.96 | |||||
Levered Free Cash Flow Margin | -0.3 | -14.77 | -7.32 | 8.75 | 12.74 | |||||
Unlevered Free Cash Flow Margin | 0.44 | -14.42 | -7.07 | 9.05 | 12.74 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.44 | 0.45 | 0.66 | 0.58 | 0.49 | |||||
Fixed Assets Turnover | 1.81 | 1.73 | 1.98 | 1.61 | 1.42 | |||||
Receivables Turnover (Average Receivables) | 4.37 | 4.74 | 6.27 | 4.96 | 4.17 | |||||
Inventory Turnover (Average Inventory) | 4.64 | 3.4 | 4.27 | 4.57 | 4.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.91 | 1.69 | 1.66 | 2.06 | 2.38 | |||||
Quick Ratio | 2.41 | 1.12 | 1.14 | 1.62 | 1.81 | |||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.35 | 0.73 | 0.91 | 0.76 | |||||
Days Sales Outstanding (Average Receivables) | 83.67 | 76.99 | 58.19 | 73.6 | 87.79 | |||||
Days Outstanding Inventory (Average Inventory) | 78.9 | 107.2 | 85.45 | 79.9 | 86.57 | |||||
Average Days Payable Outstanding | 63.21 | 66.64 | 60.6 | 61.88 | 60.94 | |||||
Cash Conversion Cycle (Average Days) | 99.35 | 117.55 | 83.03 | 91.62 | 113.41 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 13.12 | 11.05 | 12.5 | 10.35 | 14.39 | |||||
Total Debt / Total Capital | 11.6 | 9.95 | 11.11 | 9.38 | 12.58 | |||||
LT Debt/Equity | 8.82 | 4.2 | 3.76 | 3.22 | 5.93 | |||||
Long-Term Debt / Total Capital | 7.8 | 3.78 | 3.34 | 2.91 | 5.19 | |||||
Total Liabilities / Total Assets | 29.32 | 29.69 | 27.46 | 24.64 | 26.44 | |||||
EBIT / Interest Expense | 15.79 | 33.88 | 57.22 | 56.91 | - | |||||
EBITDA / Interest Expense | 20.76 | 43.58 | 67.48 | 68.34 | - | |||||
(EBITDA - Capex) / Interest Expense | 5.29 | -10.47 | 5.13 | 39.84 | - | |||||
Total Debt / EBITDA | 1.06 | 0.77 | 0.54 | 0.43 | 0.57 | |||||
Net Debt / EBITDA | -2.6 | -0.8 | -0.33 | -0.67 | -0.8 | |||||
Total Debt / (EBITDA - Capex) | 4.14 | -3.19 | 7.16 | 0.75 | 0.79 | |||||
Net Debt / (EBITDA - Capex) | -10.18 | 3.34 | -4.33 | -1.14 | -1.09 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 28.46 | 38.5 | 71.84 | 2.51 | -1.97 | |||||
Gross Profit, 1 Yr. Growth % | 24.97 | 32.14 | 76.82 | 13.25 | 10.58 | |||||
EBITDA, 1 Yr. Growth % | 18.84 | 37.57 | 95.19 | 22.22 | 22.39 | |||||
EBITA, 1 Yr. Growth % | 18.8 | 39.35 | 106.86 | 19.52 | 21.93 | |||||
EBIT, 1 Yr. Growth % | 20.18 | 40.42 | 110.39 | 20.44 | 23.03 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 56.23 | 71.99 | 73.34 | 8.96 | 42.06 | |||||
Net Income, 1 Yr. Growth % | 59.62 | 72.19 | 72.91 | 9 | -1.63 | |||||
Normalized Net Income, 1 Yr. Growth % | 25 | 76.94 | 69.87 | 21.17 | 30.02 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 56.48 | 64.76 | 63.01 | 14.89 | 0.62 | |||||
Accounts Receivable, 1 Yr. Growth % | 26 | 29.26 | 30.41 | 29.04 | -1.34 | |||||
Inventory, 1 Yr. Growth % | 54.14 | 119.86 | -4 | -16.45 | 14.01 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 30.22 | 56.25 | 46.21 | 12.7 | 0.52 | |||||
Total Assets, 1 Yr. Growth % | 58.32 | 19.09 | 17.35 | 13.88 | 9.04 | |||||
Tangible Book Value, 1 Yr. Growth % | 100.27 | 16.15 | 22.93 | 19.67 | 9.04 | |||||
Common Equity, 1 Yr. Growth % | 87.69 | 18.46 | 21.04 | 18.31 | 6.37 | |||||
Cash From Operations, 1 Yr. Growth % | 36.27 | 15.49 | 131.32 | 26.1 | -7.32 | |||||
Capital Expenditures, 1 Yr. Growth % | 19.72 | 128.84 | 43.68 | -44.64 | -27.43 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -91.89 | 6.76T | -15.12 | -227.53 | 136.82 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -113.51 | -4.61T | -16.07 | -236.85 | 123.55 | |||||
Dividend Per Share, 1 Yr. Growth % | 50.8 | 71.04 | 72.53 | 10.88 | -0.81 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 31.15 | 33.39 | 54.27 | 32.72 | -1.84 | |||||
Gross Profit, 2 Yr. CAGR % | 28.55 | 28.5 | 52.85 | 41.51 | 6.15 | |||||
EBITDA, 2 Yr. CAGR % | 27.6 | 28.36 | 64.47 | 54.85 | 16.92 | |||||
EBITA, 2 Yr. CAGR % | 29.19 | 29.28 | 70.55 | 57.7 | 14.47 | |||||
EBIT, 2 Yr. CAGR % | 29.69 | 29.91 | 71.88 | 59.19 | 14.96 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 13.12 | 63.92 | 72.66 | 37.43 | 13.25 | |||||
Net Income, 2 Yr. CAGR % | 14.43 | 65.78 | 72.55 | 37.29 | 3.55 | |||||
Normalized Net Income, 2 Yr. CAGR % | 33.86 | 48.72 | 73.37 | 43.47 | 18.81 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 5.44 | 60.9 | 63.88 | 36.85 | 7.52 | |||||
Accounts Receivable, 2 Yr. CAGR % | 32.93 | 27.62 | 29.83 | 29.72 | 12.83 | |||||
Inventory, 2 Yr. CAGR % | 67.92 | 84.09 | 45.28 | -10.44 | -2.4 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 43.42 | 42.64 | 51.14 | 28.36 | 6.43 | |||||
Total Assets, 2 Yr. CAGR % | 42.91 | 37.31 | 18.21 | 15.6 | 11.43 | |||||
Tangible Book Value, 2 Yr. CAGR % | 37.52 | 52.52 | 19.49 | 21.29 | 14.23 | |||||
Common Equity, 2 Yr. CAGR % | 35.54 | 49.11 | 19.74 | 19.67 | 12.18 | |||||
Cash From Operations, 2 Yr. CAGR % | 55.64 | 25.45 | 63.45 | 70.79 | 8.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | 16.09 | 65.52 | 81.33 | -10.82 | -36.62 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -80.77 | 134.16 | 664.76 | 1.93 | 32.13 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -76.34 | 148.01 | 516.45 | 4.91 | 34.58 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.76 | 60.6 | 71.78 | 38.31 | 4.87 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 28.65 | 33.56 | 45.14 | 34.62 | 18.3 | |||||
Gross Profit, 3 Yr. CAGR % | 24.48 | 29.73 | 42.93 | 38.32 | 25.83 | |||||
EBITDA, 3 Yr. CAGR % | 23.73 | 31.17 | 47.97 | 49.23 | 38.94 | |||||
EBITA, 3 Yr. CAGR % | 23.12 | 32.91 | 51.67 | 51.79 | 39.7 | |||||
EBIT, 3 Yr. CAGR % | 23.41 | 33.17 | 52.56 | 52.67 | 40.62 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 32.06 | 30.07 | 67 | 48.1 | 30.51 | |||||
Net Income, 3 Yr. CAGR % | 34.12 | 31.13 | 68.13 | 48.05 | 22.85 | |||||
Normalized Net Income, 3 Yr. CAGR % | 31.19 | 46.91 | 55.46 | 53.85 | 33.84 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.68 | 22.53 | 61.6 | 45.59 | 23.52 | |||||
Accounts Receivable, 3 Yr. CAGR % | 38.13 | 31.7 | 28.54 | 29.57 | 18.41 | |||||
Inventory, 3 Yr. CAGR % | 54.59 | 83.71 | 48.17 | 20.81 | -2.94 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 41.07 | 47.58 | 43.82 | 37.06 | 18.32 | |||||
Total Assets, 3 Yr. CAGR % | 54.38 | 34.48 | 30.3 | 16.75 | 13.37 | |||||
Tangible Book Value, 3 Yr. CAGR % | 82.43 | 29.99 | 41.94 | 19.55 | 17.06 | |||||
Common Equity, 3 Yr. CAGR % | 72.39 | 29.59 | 39.1 | 19.26 | 15.06 | |||||
Cash From Operations, 3 Yr. CAGR % | 30.36 | 40.91 | 53.84 | 49.91 | 39.31 | |||||
Capital Expenditures, 3 Yr. CAGR % | 30.52 | 45.56 | 57.89 | 22.09 | -16.74 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -61.66 | 35.72 | 67.2 | 315.22 | 12.46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -56.09 | 36.61 | 73.07 | 267.99 | 13.36 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 28.02 | 64.48 | 48.46 | 23.8 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 27.63 | 30.22 | 38.35 | 33.22 | 24.12 | |||||
Gross Profit, 5 Yr. CAGR % | 30.07 | 27.15 | 35.13 | 34.32 | 26.89 | |||||
EBITDA, 5 Yr. CAGR % | 36.93 | 28.02 | 38.87 | 40.39 | 34.8 | |||||
EBITA, 5 Yr. CAGR % | 44.01 | 28.64 | 40.53 | 42.58 | 35.68 | |||||
EBIT, 5 Yr. CAGR % | 44.32 | 28.61 | 40.9 | 43.02 | 36.23 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 34.29 | 35.58 | 47.01 | 32.97 | 42.97 | |||||
Net Income, 5 Yr. CAGR % | 53.36 | 39.21 | 48.34 | 33.56 | 38.5 | |||||
Normalized Net Income, 5 Yr. CAGR % | 65.37 | 38.62 | 46.66 | 45.52 | 39.61 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 44.7 | 30.32 | 38.53 | 28.07 | 37.3 | |||||
Accounts Receivable, 5 Yr. CAGR % | 23.39 | 31.57 | 34.75 | 30.9 | 22.01 | |||||
Inventory, 5 Yr. CAGR % | 60.5 | 63.12 | 50.8 | 37.82 | 25.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 35.33 | 43.15 | 45.01 | 39.57 | 27.5 | |||||
Total Assets, 5 Yr. CAGR % | 36.73 | 39.09 | 38.75 | 26.58 | 22.4 | |||||
Tangible Book Value, 5 Yr. CAGR % | 60.76 | 47.96 | 54.03 | 26.44 | 30.13 | |||||
Common Equity, 5 Yr. CAGR % | 57.36 | 47.2 | 49.01 | 25.52 | 27.63 | |||||
Cash From Operations, 5 Yr. CAGR % | 40.01 | 21.17 | 42.71 | 52.18 | 33.59 | |||||
Capital Expenditures, 5 Yr. CAGR % | 26.69 | 48.59 | 48.86 | 19.66 | 9.6 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -40.79 | 0.26 | 26.58 | 21.14 | 50.93 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -35.89 | -0.28 | 26.57 | 23.02 | 55.18 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 32.04 | 37.38 |
- Stock Market
- Equities
- 603259 Stock
- Financials WuXi AppTec Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















